Literature DB >> 22595988

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome.

D Keszthelyi1, F J Troost, A A Masclee.   

Abstract

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder, characterized by recurrent abdominal pain or discomfort in combination with disturbed bowel habits in the absence of identifiable organic cause. Visceral hypersensitivity has emerged as a key hypothesis in explaining the painful symptoms in IBS and has been proposed as a "biological hallmark" for the condition. Current techniques of assessing visceral perception include the computerized barostat using rectal distensions, registering responses induced by sensory stimuli including the flexor reflex and cerebral evoked potentials, as well as brain imaging modalities such as functional magnetic resonance imaging and positron emission tomography. These methods have provided further insight into alterations in pain processing in IBS, although the most optimal method and condition remain to be established. In an attempt to give an overview of these methods, a literature search in the electronic databases PubMed and MEDLINE was executed using the search terms "assessment of visceral pain/visceral nociception/visceral hypersensitivity" and "irritable bowel syndrome." Both original articles and review articles were considered for data extraction. This review aims to discuss currently used modalities in assessing visceral perception, along with advantages and limitations, and aims also to define future directions for methodological aspects in visceral pain research. Although novel paradigms such as brain imaging and neurophysiological recordings have been introduced in the study of visceral pain, confirmative studies are warranted to establish their robustness and clinical relevance. Therefore, subjective verbal reporting following rectal distension currently remains the best-validated technique in assessing visceral perception in IBS.

Entities:  

Mesh:

Year:  2012        PMID: 22595988     DOI: 10.1152/ajpgi.00060.2012

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  54 in total

1.  Probiotic treatment induced change of inflammation related metabolites in IBS-D patients/double-blind, randomized, placebo-controlled trial.

Authors:  Jinjoo Kim; Kumsun Cho; Joo Sung Kim; Hyun Chae Jung; Bumsik Kim; Myeong Soo Park; Geun Eog Ji; Joo-Youn Cho; Kyoung Sup Hong
Journal:  Food Sci Biotechnol       Date:  2019-12-23       Impact factor: 2.391

2.  Increased Gut Permeability in First-degree Relatives of Children with Irritable Bowel Syndrome or Functional Abdominal Pain.

Authors:  Mark McOmber; Danny Rafati; Kevin Cain; Sridevi Devaraj; Erica M Weidler; Margaret Heitkemper; Robert J Shulman
Journal:  Clin Gastroenterol Hepatol       Date:  2019-05-14       Impact factor: 11.382

3.  Neural circuitry underlying effects of context on human pain-related fear extinction in a renewal paradigm.

Authors:  Adriane Icenhour; Joswin Kattoor; Sven Benson; Armgard Boekstegers; Marc Schlamann; Christian J Merz; Michael Forsting; Sigrid Elsenbruch
Journal:  Hum Brain Mapp       Date:  2015-06-09       Impact factor: 5.038

Review 4.  [Psychophysiology of visceral pain].

Authors:  B Horing; P Enck
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

5.  Ameliorative effect of chlorpromazine hydrochloride on visceral hypersensitivity in rats: possible involvement of 5-HT2A receptor.

Authors:  Teita Asano; Ken-Ichiro Tanaka; Arisa Tada; Hikaru Shimamura; Rikako Tanaka; Hiroki Maruoka; Tohru Mizushima; Mitsuko Takenaga
Journal:  Br J Pharmacol       Date:  2017-08-23       Impact factor: 8.739

Review 6.  Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.

Authors:  Tina Didari; Shilan Mozaffari; Shekoufeh Nikfar; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

7.  Abnormalities in the thalamo-cortical network in patients with functional constipation.

Authors:  Lei Liu; Chunxin Hu; Yang Hu; Wenchao Zhang; Zhida Zhang; Yueyan Ding; Yuanyuan Wang; Karen M von Deneen; Lijuan Sun; Huaning Wang; Shijun Duan; Kuanrong Mao; Fan Wang; Guangbin Cui; Jixin Liu; Yongzhan Nie; Yi Zhang
Journal:  Brain Imaging Behav       Date:  2021-04       Impact factor: 3.978

8.  Effectiveness of acupuncture to treat irritable bowel syndrome: a meta-analysis.

Authors:  Guan-Qun Chao; Shuo Zhang
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

9.  Comparison of Electroacupuncture and Mild-Warm Moxibustion on Brain-Gut Function in Patients with Constipation-Predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.

Authors:  Ji-Meng Zhao; Jin-Hua Lu; Xiao-Jun Yin; Lu-Yi Wu; Chun-Hui Bao; Xing-Kui Chen; Yue-Hua Chen; Wei-Jun Tang; Xiao-Ming Jin; Huan-Gan Wu; Yin Shi
Journal:  Chin J Integr Med       Date:  2018-05-11       Impact factor: 1.978

10.  Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.

Authors:  Feng-Yan Yu; Shao-Gang Huang; Hai-Yan Zhang; Hua Ye; Hong-Gang Chi; Ying Zou; Ru-Xi Lv; Xue-Bao Zheng
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.